متابعة
Michael Koslowski
Michael Koslowski
بريد إلكتروني تم التحقق منه على charite.de
عنوان
عدد مرات الاقتباسات
عدد مرات الاقتباسات
السنة
Dysfunction of ventral striatal reward prediction in schizophrenia
G Juckel, F Schlagenhauf, M Koslowski, T Wüstenberg, A Villringer, ...
Neuroimage 29 (2), 409-416, 2006
7492006
Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics
G Juckel, F Schlagenhauf, M Koslowski, D Filonov, T Wüstenberg, ...
Psychopharmacology 187, 222-228, 2006
3952006
Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine
F Schlagenhauf, G Juckel, M Koslowski, T Kahnt, B Knutson, T Dembler, ...
Psychopharmacology 196, 673-684, 2008
2672008
Learning to let go: a cognitive-behavioral model of how psychedelic therapy promotes acceptance
M Wolff, R Evens, LJ Mertens, M Koslowski, F Betzler, G Gründer, ...
Frontiers in psychiatry 11, 5, 2020
1542020
Regional patterns and clinical correlates of basal ganglia morphology in non-medicated schizophrenia
M Ballmaier, F Schlagenhauf, AW Toga, J Gallinat, M Koslowski, M Zoli, ...
Schizophrenia research 106 (2-3), 140-147, 2008
992008
Ventral striatal activation during reward processing in subjects with ultra-high risk for schizophrenia
G Juckel, E Friedel, M Koslowski, H Witthaus, S Özgürdal, Y Gudlowski, ...
Neuropsychobiology 66 (1), 50-56, 2012
962012
Chorea in systemic lupus erythematosus
JF Baizabal-Carvallo, M Alonso-Juarez, M Koslowski
JCR: Journal of Clinical Rheumatology 17 (2), 69-72, 2011
692011
Switching schizophrenia patients from typical neuroleptics to olanzapine: effects on BOLD response during attention and working memory
F Schlagenhauf, T Wüstenberg, K Schmack, M Dinges, J Wrase, ...
European Neuropsychopharmacology 18 (8), 589-599, 2008
612008
Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE)–Rationale and study design
LJ Mertens, M Koslowski, F Betzler, R Evens, M Gilles, A Jungaberle, ...
Neuroscience Applied 1, 100104, 2022
282022
Novel treatment approaches for substance use disorders: Therapeutic use of psychedelics and the role of psychotherapy
M Koslowski, MW Johnson, G Gründer, F Betzler
Current Addiction Reports, 1-11, 2021
212021
Using routine MRI data of depressed patients to predict individual responses to electroconvulsive therapy
M Gärtner, E Ghisu, AL Herrera-Melendez, M Koslowski, S Aust, P Asbach, ...
Experimental neurology 335, 113505, 2021
162021
Converging theories on dreaming: Between Freud, predictive processing, and psychedelic research
M Koslowski, MP de Haas, T Fischmann
Frontiers in Human Neuroscience 17, 1080177, 2023
82023
Cannabis use, use motives and cannabis use disorder among Berlin college students
H Naegele, F Betzler, L Viohl, M Koslowski, F Ernst, MB Petzold
Journal of Drug Issues 52 (4), 568-584, 2022
82022
Le rôle de la psychothérapie dans la thérapie assistée par les psychédéliques
M Koslowski, C Dauré, M Ljuslin
L'information psychiatrique 99 (10), 703-709, 2023
22023
Guiding Through Challenging Psychedelic Experiences and “Bad Trips”
M Koslowski, P Gasser
12024
Ethische Aspekte der Therapie mit Psychedelika
D Repantis, M Koslowski, SB Fink
Die Psychotherapie 69 (2), 115-121, 2024
12024
Ventral striatum activation by typical versus atypical neuroleptics in a fMRI paradigm with monetary incentive stimuli
G Juckel, F Schlagenhauf, M Koslowski, D Filonow, B Knutson, J Wrase, ...
Pharmacopsychiatry 38 (05), A109, 2005
12005
A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research
DB Yaden, M Graziosi, AM Owen, G Agin-Liebes, ST Aaronson, KE Allen, ...
Psychedelic Medicine, 2025
2025
Therapie mit Psychedelika
M Koslowski, A Ströhle
Die Psychotherapie 69 (2), 83-84, 2024
2024
Ethical aspects of therapy with psychedelics
D Repantis, M Koslowski, SB Fink
PSYCHOTHERAPIE, 2024
2024
يتعذر على النظام إجراء العملية في الوقت الحالي. عاود المحاولة لاحقًا.
مقالات 1–20